Torrent Pharmaceuticals Dividend
Dividend criteria checks 4/6
Torrent Pharmaceuticals ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 1.15%, die durch die Erträge gut gedeckt ist.
Key information
1.2%
Dividend yield
68%
Payout ratio
Industry average yield | 0.7% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | ₹44.15 |
Dividend yield forecast in 3Y | 1.0% |
Recent dividend updates
Recent updates
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 03Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00
Feb 05Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings
Jan 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly
Nov 14Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jun 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Mar 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 25Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture
Jun 02Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
May 25A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Feb 18Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00
Jan 27Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly
Jan 04Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock
Dec 14A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Nov 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Sep 30Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?
Sep 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 02I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease
Jun 01Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate
May 14Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 23The Torrent Pharmaceuticals (NSE:TORNTPHARM) Share Price Has Gained 84% And Shareholders Are Hoping For More
Mar 02Is It Smart To Buy Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Before It Goes Ex-Dividend?
Feb 10Do Torrent Pharmaceuticals's (NSE:TORNTPHARM) Earnings Warrant Your Attention?
Jan 19Should You Be Impressed By Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) ROE?
Dec 29Is Torrent Pharmaceuticals (NSE:TORNTPHARM) Using Too Much Debt?
Dec 08Investors Who Bought Torrent Pharmaceuticals (NSE:TORNTPHARM) Shares Three Years Ago Are Now Up 118%
Nov 16The Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
Oct 28Here's Why We Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Well Worth Watching
Oct 07Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Delivered A Better ROE Than Its Industry
Sep 16We Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Stay On Top Of Its Debt
Aug 26Stability and Growth of Payments
Fetching dividends data
Stabile Dividende: TORNTPHARMDie Dividendenzahlungen des Unternehmens waren in den vergangenen 10 Jahren volatil.
Wachsende Dividende: TORNTPHARM Die Dividendenzahlungen des Unternehmens sind in den letzten 10 Jahren gestiegen.
Dividend Yield vs Market
Torrent Pharmaceuticals Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (TORNTPHARM) | 1.2% |
Market Bottom 25% (IN) | 0.3% |
Market Top 25% (IN) | 1.2% |
Industry Average (Pharmaceuticals) | 0.7% |
Analyst forecast in 3 Years (TORNTPHARM) | 1.0% |
Bemerkenswerte Dividende: TORNTPHARMDie Dividende des Unternehmens (1.15%) ist höher als die der untersten 25% der Dividendenzahler auf dem Markt Indian (0.27%).
Hohe Dividende: TORNTPHARMDie Dividende des Unternehmens (1.15%) ist im Vergleich zu den besten 25% der Dividendenzahler auf dem Markt Indian (1.17%) niedrig.
Earnings Payout to Shareholders
Abdeckung der Erträge: Mit einer angemessenen Ausschüttungsquote (67.9%) sind die Dividendenzahlungen von TORNTPHARM durch die Gewinne gedeckt.
Cash Payout to Shareholders
Cashflow-Deckung: Mit einer relativ niedrigen Ausschüttungsquote (41.9%) sind die Dividendenzahlungen von TORNTPHARM durch den Cashflow gut gedeckt.